Finally, our study did not measure other cardio-metabolic biomarkers such as blood glucose, insulin, lipids, triglycerides and C-peptide, and thus lacking outcomes such as dysglycemia or dyslipidemia. The gene discussed is INS; the disease is metabolic syndrome.